Canary Capital's staked Injective ETF started trading on Nasdaq under ticker INJC on November 5, becoming the first US exchange-traded fund focused on the INJ token. The fund plans to stake at least 90% of its holdings and charges a 1.10% management fee plus roughly 30% of staking rewards. BitGo acts as custodian while net assets total around $15 million.
INJ climbed approximately 5% to $8.23 following the launch, gaining 10% for the week despite broader crypto market losses. First-day trading volume for INJC reached only 2,933 shares, far below debuts for similar products. Two additional INJ ETF applications remain pending, and market watchers say sustained performance depends on flows and trading metrics rather than initial price moves.
Read the full story on BSC News: Injective (INJ) Rises as Canary Capital Launches First US Staked INJ ETF on Nasdaq
Want the day's biggest crypto stories in one email each morning? Subscribe to The BSCN Debrief